Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation.
D000328:Adult; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D016729:Leuprolide; D008183:Luteal Phase; D010053:Ovary / Q000187:drug effects / Q000502:physiology*; D010062:Ovulation Induction; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000139:chemically induced
D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide